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Limited Maximal Exercise Capacity
in Patients With Chronic Heart Failure
Partitioning the Contributors
Fabio Esposito, MD,*† Odile Mathieu-Costello, PHD,† Ralph Shabetai, MD,†
Peter D. Wagner, MD,† Russell S. Richardson, PHD‡§
Milan, Italy; La Jolla, California; and Salt Lake City, Utah
Objectives This study aimed to assess the factors limiting maximal exercise capacity in patients with chronic heart failure
(CHF).
Background Maximal exercise capacity, an important index of health in CHF, might be limited by central and/or peripheral
factors; however, their contributions remain poorly understood.
Methods We studied oxygen (O2) transport and metabolism at maximal cycle (centrally taxing) and knee-extensor (KE)
(peripherally taxing) exercise in 12 patients with CHF and 8 healthy control subjects in normoxia and hyperoxia
(100% O2).
Results Peak oxygen uptake (VO2) while cycling was 33% lower in CHF patients than in control subjects. By experimental
design, peak cardiac output was reduced during KE exercise when compared with cycling (approximately 35%);
although muscle mass specific peak leg VO2 was increased equally in both groups (approximately 70%), VO2 in
the CHF patients was still 28% lower. Hyperoxia increased O2 carriage in all cases but only facilitated a 7% in-
crease in peak leg VO2 in the CHF patients during cycling, the most likely scenario to benefit from increased O2
delivery. Several relationships, peak leg VO2 (KE  cycle) to capillary-fiber-ratio and capillaries around a fiber to
mitochondrial volume, were similar in both groups (r  0.6–0.7).
Conclusions Multiple independent observations, including a significant skeletal muscle metabolic reserve, suggest skeletal
muscle per se contributes minimally to limiting maximal cycle exercise in CHF or healthy control subjects. How-
ever, the consistent attenuation of the convective and diffusive components of O2 transport (25% to 30%) in pa-
tients with CHF during both cycle and even KE exercise compared with control subjects reveals an underlying
peripheral O2 transport limitation from blood to skeletal muscle in this pathology. (J Am Coll Cardiol 2010;55:
1945–54) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.086c
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txercise intolerance is widely recognized as a defining
ymptom in patients with chronic heart failure (CHF),
imiting physical activity and impairing quality of life (1).
raditionally, this attenuated exercise capacity has been
ttributed predominantly to the “central” limitations asso-
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009, accepted November 23, 2009.iated with a malfunctioning cardiac pump. However,
ttention has turned toward “peripheral” factors that might
lso contribute to the limited exercise capacity associated
ith CHF. A variety of alterations specific to both skeletal
uscle (muscle atrophy, fiber type changes, reduced mito-
hondrial enzymes, decreased mitochondrial volume den-
ity) (1– 4) and the vascular/skeletal muscle interface
greater sympathetic vasoconstrictor tone, decreased capil-
arity, and smaller capillary diameter) (5–7) have all been
ssociated with CHF. However, the contribution of these
keletal muscle changes to limited exercise capacity in CHF
s currently not well understood.
Studies of exercise limitation in CHF have predomi-
antly used standard cycle ergometry, resulting in the
ecruitment of most of the muscles in the lower limbs
nd—to some extent— upper body muscles to accomplish
he work (Fig. 1A) (8,9). With the limited maximal
ardiac output associated with CHF, the involvement of
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Limitations to Maximal Exercise in CHF May 4, 2010:1945–54such a large muscle mass is
thought to be the major factor
attenuating maximal exercise in
this population. Although it
has previously been recognized
that skeletal muscle function
and plasticity in CHF might be
better assessed by changing ex-
ercise modality from conven-
tional cycle exercise to a small
muscle mass exercise, such as
single-leg knee-extension (Fig.
1B) (9 –14), identifying the role
of centrally limited oxygen (O2)
supply versus compromised pe-
ripheral O2 use (15,16) in both
ealthy matched control subjects and patients with CHF
as never been attempted.
An additional approach to better understand exercise
imitations due to O2 availability has been to raise inspired
2 concentration above that of ambient air. This method
as identified exercise-trained humans as O2-supply-limited
8,17) and their sedentary counterparts as O2-demand-
imited (16). However, supplemental O2 use in CHF has
Figure 1 Exercise Modalities
A schematic representation of the relatively small ratio of cardiac capacity to
skeletal muscle recruitment during standard cycle ergometry (A), the much
greater ratio during single-leg knee-extension (B), and the subsequently con-
trasting physiological responses to these exercise paradigms.
Abbreviations
and Acronyms
CaO2  arterial oxygen
concentration
CHF  chronic heart failure
CvO2  venous oxygen
content
DMO2  diffusional oxygen
conductance
KE  knee-extensor
NE  norepinephrine
O2  oxygen
QO2  oxygen delivery
VO2  oxygen uptakepot been commonly employed, and the limited results have
een equivocal (18–20). We contend that this technique has
et to be applied, in earnest, to the question of what limits
xercise capacity in patients with CHF.
Consequently, the present study used conventional cycle
rgometry and single-leg knee-extensor (KE) exercise to
reatly vary muscle mass recruitment in both CHF patients
nd healthy matched control subjects in both normoxia and
yperoxia (100% O2) (Fig. 1). This allowed us to test the
ollowing hypotheses: 1) during conventional cycle exercise,
hen muscle mass is large in relation to the compromised
ardiac output, CHF patients will demonstrate limited
xercise capacity, predominantly explained by cardiac fail-
re; 2) when patients with CHF are somewhat artificially
reed from this cardiac limited O2 delivery at maximal
xercise, by performing KE exercise or breathing hyperoxia
o increase O2 availability at the exercising muscle, there will
e evidence of a skeletal muscle metabolic reserve; and
) under these more optimal conditions for muscle metabolism
here will still be evidence of limited O2 transport and
ubsequent skeletal muscle dysfunction in patients with CHF
ompared with control subjects, due to inherent abnormalities
n peripheral O2 transport associated with this pathology.
ethods
ubjects. Twelve male patients with CHF and 8 healthy
ontrol subjects volunteered and gave written consent to
articipate in the study, which had been approved by the
niversity of California at San Diego Human Subjects
rotection Program. All CHF patients were clinically stable
nd had symptoms compatible with New York Heart
ssociation functional class II to III (n  5 and n  7,
espectively). Mean left ventricular ejection fraction in the
HF patients was 25  3%. Other than beta-blockers,
hich were withheld for 48 h before the studies, patient
edications were not altered. Particular care was taken to
atch control subjects for age, sex, quadriceps muscle mass,
nd physical activity by questionnaire and interview (Table 1).
atheter placement and experimental protocol. A radial
rterial and common femoral venous line in addition to a
hermocouple in the common femoral vein were placed
pon arrival at the laboratory, as previously described (21).
ith catheters in place, both the patients with CHF and
ontrol subjects underwent 4 exercise tests in a balanced
esign, separated by at least 1.5 h for recovery (cycle and KE
xercise in both normoxia and hyperoxia [100% O2]). In
ach trial, exercise intensity was increased progressively
very 2 min to exhaustion.
xercise modalities. Cycle exercise was performed on an
lectromagnetically braked cycle ergometer (Lode Excalibur
port, Quinton Instruments, Inc., Groningon, the Nether-
ands). During KE exercise, the subject was seated on an
djustable chair with the ankle of 1 leg attached by a rigid
ar to a cycle ergometer (Monark, Stockholm, Sweden), as
reviously described (10) (Fig. 1).
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May 4, 2010:1945–54 Limitations to Maximal Exercise in CHFeasurements and calculations. Mixed expired O2 and
arbon dioxide, expiratory air flow, and electrocardiography
ere continuously recorded and digitized (Parvo Medics,
alt Lake City, Utah). Simultaneous arterial and femoral
enous blood samples were collected at rest and during the
econd and third minutes of each incremental work rate. At
ach level of work, the following variables were measured:
) O2 partial pressure, carbon dioxide partial pressure, pH
IL model 1302, pH/blood gas analyzer; Instrumentation
aboratories, Milan, Italy), oxyhemoglobin saturation, he-
oglobin concentration (IL 482 co-oximeter), and lysed
hole-blood lactate concentrations (YSI 23L blood lactate
nalyzer; Yellow Springs Instruments, Yellow Springs,
hio) from simultaneous arterial and common femoral
enous blood samples (blood gas values were corrected to
he temperature measured in the common femoral vein);
nd 2) common femoral venous blood flow (thermodilution)
nd arterial and venous vascular pressures (10). Technical
spects of these measurements and subsequent calculations
ave been previously provided in detail (17,22).
ardiac output. Cardiac output was measured in duplicate
t rest and during exercise with an open-circuit acetylene
ptake technique, as described previously (23).
atecholamines. Plasma epinephrine and norepinephrine
NE) were assayed in duplicate by the method of Kennedy
nd Zeigler (24), and the rate of NE spillover was deter-
ined as described previously (25) with the following
quation:
NE spillover  [(Cv  Ca)  Ca (Ee)] LPF
here Cv and Ca are plasma NE concentrations in the
ommon femoral vein and radial artery, respectively; Ee is
haracteristics of Control Subjectsnd CHF Pa ientsTable 1 Characteristics of Control Subjectsand CHF Patients
Control Subjects
(n  8)
CHF
(n  12)
Age (yrs) 52 2 53 1
Height (cm) 177 2 179 2
Body mass (kg) 88 5 98 6
Knee extensor (1-leg) muscle mass (kg) 2.2 0.1 2.2 0.1
NYHA functional class — IIIII
Medications (no. of users)
Digoxin 0 12
Diuretics 0 12
Long-acting nitrates 0 7
Statins 0 6
Aspirin 0 7
Beta-blockers 0 10
Warfarin 0 4
ACE inhibitors 0 9
Ca channel blockers 0 3
nthropometric data, severity of disease (New York Heart Association functional class) and
edications in chronic heart failure (CHF) patients and control subjects. Data are expressed as
ean  SEM; p  0.05.
ACE  angiotensin-converting enzyme; Ca  calcium, doubly charged positive ion.he fractional extraction of epinephrine; and LPF is the leg alasma flow, determined from leg blood flow and
ematocrit.
uscle mass. With the use of thigh length, circumfer-
nces, and skin-fold measurements, thigh volume was cal-
ulated to allow an estimate of quadriceps muscle mass, as
sed previously (10,26). During cycle exercise, the amount
f working muscle mass was estimated on the basis of the
eported ratio of quadriceps muscle mass to other leg
uscles, in a fashion similar to that for our previous
stimations (8).
uscle biopsy. On a different day, a percutaneous biopsy
f vastus lateralis muscle was obtained (Bergstrom needle)
rom 9 of the 12 CHF patients and 6 of the 8 control
ubjects, as previously described (20).
istochemistry. Transverse sections (8-mm-thick) were
ut at 24°C on a cryostat (Jung-Reichert Cryocut 1800;
ambridge Instruments, Heidelberg, Germany) and kept at
20°C until histochemical processing, which was per-
ormed within a week of sectioning. After 5-min fixation in
Guth and Samaha fixative at room temperature, sections
ere incubated at 37°C for 1 h in lead (Pb)-adenosine
riphosphatase staining medium to simultaneously stain for
ber types I and II and capillaries (27).
issue preparation for microscopy. The glutaraldehyde-
xed samples were completely cut into thin longitudinal
trips and processed for electron microscopy as described
reviously (28). Electron micrographs for morphometry
ere taken on 70-mm films with a Zeiss 10 electron
icroscope (Zeiss, Peabody, Massachusetts).
orphometry. The relative cross-sectional area and number
f type I and type II fibers was estimated under a light
icroscope (250) on histochemical sections by point-
ounting with an eyepiece square grid test A100 (29). Capillary
ensity (i.e., capillary number/fiber cross-sectional area), cap-
llary/fiber ratio (i.e., capillary number/fiber number), capillary
umber around a fiber, and fiber cross-sectional area were
easured by point-counting on 1-m-thick sections examined
t a magnification of 400 with a light microscope. The
olume density of mitochondria/volume of muscle fiber was
stimated by point-counting at a final magnification of
9,000 on ultrathin transverse sections.
tatistical analysis. Data were analyzed with parametric
tatistics, after mathematical confirmation of normal distribu-
ion with Shapiro-Wilk tests. Between-group subject charac-
eristics were assessed with independent samples t tests. Com-
arisons of CHF patients and control data collected during
xercise were performed with both 2-way (health status [2
evels] and exercise modality [2 levels]) and 3-way (health
tatus [2 levels], exercise modality [2 levels], and inspirate [2
evels]) analyses of variance (repeated measures). After a
ignificant main effect and interaction, paired samples t tests
ere employed to make post hoc comparisons at each level of
he within-subjects factor. The relationship between selected
ariables was identified with a Pearson Product Moment
orrelation. Statistical significance was set at p  0.05. Datare expressed as mean  SEM.
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Limitations to Maximal Exercise in CHF May 4, 2010:1945–54esults
he Shapiro-Wilk tests revealed p values of  0.05; thus
he null hypothesis that the data were normally distributed
as not rejected, and parametric statistics were employed.
ost hoc power analyses on the statistical comparisons of
ajor variables that revealed a difference between patients
ith CHF and control subjects (e.g., work load, cardiac
utput, blood flow, O2 delivery, oxygen uptake [VO2],
iffusional oxygen conductance [DMO2], venous O2 partial
ressure) all demonstrated a power of 0.78.
There were no statistically significant differences in the
hysical characteristics of the patients with CHF and
ontrol subjects, and these data are presented in Table 1.
he work rate and cardiovascular responses at maximal cycle
xercise and KE exercise in CHF and control subjects are
resented in Table 2 with specific highlights presented in
he following sections.
Cardiovascular Responses to Maximal Normoxicand KE Exercise in Control Subjects and CHF PaTable 2 Card ovascular Respon es t Ma mand KE Exercise in Control Subjects
Cyc
Control Subjects
Work load (W) 148 11
Pulm VO2 (l/min) 2.03 0.11
Pulm VO2 (ml/kg/min) 21.2 1.7
Pulm VCO2 (l/min) 2.13 0.16
RER 1.05 0.03
VE (l/min) 83.2 7.6
Cardiac output (l/min) 15.5 1.6
HR (beats/min) 156 11
Leg blood flow (l/min) 4.93 0.55
Leg blood flow (ml/min/100 g) 94 9.0
Leg O2 delivery (l/min) 1.00 0.11
Leg VO2 (l/min) 0.75 0.07
Leg VO2 (ml/min/100 g) 11.7 1.0
DMO2 (ml/min/mm Hg) 18.5 1.1
Fem arterial pressure (mm Hg) 129 18
Fem venous pressure (mm Hg) 18 4
Leg vasc res (mm Hg/ml/s) 1.45 0.29
CaO2 (ml/100 ml) 20.3 0.4
CaO2–CvO2 (ml/100 ml) 15.4 0.8
PaO2 (mm Hg) 97 7
PaCO2 (mm Hg) 31.9 1.9
SaO2 (%) 96 1
[Hb] (g/dl) 15.0 0.3
pHa 7.32 0.02
[La]a (mmol/l) 6.7 1.0
PvO2 (mm Hg) 21.8 2.2
PvCO2 (mm Hg) 68.6 4.2
SvO2 (%) 23 4
PcapO2 (mm Hg) 41.1 1.7
Cardiovascular responses to maximal normoxic cycle and knee-exten
failure (CHF) (n  12). Results are expressed as mean  SEM. *p 
CaO2  arterial oxygen content; CaO2-CvO2  arterial  venous o
[Hb]a  arterial hemoglobin concentration; HR  heart rate; [La]a 
VO2 1-leg oxygen uptake; PaO2 and PaCO2 oxygen and carbon dio
of oxygen in the capillaries of the exercising muscle; pHa arterial pH;
dioxide uptake; PvO2 and PvCO2  oxygen and carbon dioxide partial pressur
ratio; SaO2  arterial oxygen saturation; SvO2  venous oxygen saturation; Vardiac output during maximal cycle and KE exercise.
aximal cardiac output, attained by graded maximal
ycle exercise, was 33% lower in the patients with CHF
p  0.05). Despite being significantly lower than cardiac
utput during cycling, cardiac output in the patients with
HF at peak KE exercise was similarly attenuated by
8% (Table 2). However, the highest cardiac output
ttained in the CHF patients during this small muscle
ass exercise modality (2.2 kg in both CHF and control
ubjects) (Table 1)— essential to the premise of the
urrent experimental design—was 27% lower than that
chieved during cycle exercise in this group (Table 2)
p  0.05), documenting a functional cardiac reserve
uring KE exercise. The same observation was made in
he control subjects who also only used 67% of their
aximal cardiac output during maximal KE exercise
Table 2), although this is of less importance in terms of
lesormoxic Cycle
CHF Patients
KE
CHF Control Subjects CHF
96 8* 35 4 24 4*
52 0.15* 1.08 0.16 0.78 0.04*
.2 1.1* 11.3 1.4 7.8 0.5*
69 0.13* 0.89 0.10 0.73 0.04*
09 0.02 0.86 0.06 0.96 0.06
.0 5.0 36.8 4.4 36.0 3.0
.4 1.1* 10.3 1.6 7.5 0.7*
48 5 113 8 112 5
42 0.27* 3.34 0.37 2.50 0.21*
51 5* 152 8 112 10*
65 0.06* 0.65 0.07 0.45 0.04*
52 0.04* 0.46 0.05 0.34 0.02*
.7 0.5* 21.1 2.1 15.3 1.3*
.6 0.7* 11.1 0.9 8.7 0.7*
15 8 147 12 117 5*
14 1 17 5 17 2
91 0.19 2.45 0.33 2.54 0.19
.8 0.5* 19.5 0.3 18.0 0.6*
.6 0.5 13.7 0.7 13.6 0.5
99 5 112 4 102 4
.5 0.8* 31.5 0.9 30.6 1.0*
96 1 97 1 97 1
.9 0.4* 14.2 0.2 13.2 0.4*
37 0.01* 7.39 0.01 7.41 0.01*
.4 0.6 3.1 0.4 2.6 0.2
.8 1.3 23.4 1.2 20.6 1.0
.5 1.7* 65.7 2.5 63.8 2.3
22 2 29 3 23 2
.6 1.2 41.6 0.9 39.2 0.8
) exercise in control subjects (n  8) and patients with chronic heart
HF vs. control subjects).
ontent difference; DMO2  muscle oxygen diffusional conductance;
lactate concentration; Leg vasc res  1-leg vascular resistance; Leg
rtial pressures in arterial blood; PcapO2 calculated partial pressure
2 pulmonary peak oxygen uptake; pulm VCO2 pulmonary carbonCyctiental N
and
le
1.
15
1.
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76
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1
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0.
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1
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7.
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0.05 (C
xygen c
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xide pa
pulm VOes in femoral venous blood, respectively; RER  respiratory exchange
E  ventilation.
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[e]a  arterial epinephrine concentration; [e]v  femoral venous epinep
NE spillover  norepinephrine spillover in 1 leg; [NE]v  femoral venous nore
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May 4, 2010:1945–54 Limitations to Maximal Exercise in CHFxperimental design. Heart rate, measured indepen-
ently, also supports the existence of a cardiac reserve in
oth groups, with a 24% and 28% lower heart rate attained
uring KE exercise in comparison with cycle exercise in the
atients with CHF and control subjects, respectively (Table 2).
uscle VO2 during maximal cycle and KE exercise.
uring cycle exercise, there was a proportional attenua-
ion in maximal work rate (35%) and absolute peak leg
O2 (31%) in the patients with CHF compared with
ontrol subjects. Likewise during KE exercise, the pa-
ients did not achieve the same maximal work rate (31%
ower) and peak leg VO2 (26% lower) as the control
ubjects (Table 2). However, in CHF and control sub-
ects, both peak leg VO2 and peak muscle blood flow were
ignificantly elevated by the transition from cycle to KE
xercise when normalized by the estimated muscle mass used
uring the exercise (Table 2).
xygen transport during cycle and KE exercise. At
aximal cycle and KE exercise, leg blood flow in the CHF
atients was 31% and 25% lower, respectively, than in
ontrol subjects, and arterial O2 content was slightly but
ignificantly lower in CHF than in control subjects, due to
small but significantly different hemoglobin concentration
etween the 2 groups (Table 2). As a consequence, leg O2
elivery was 35% and 26% lower during cycling and KE
xercise, respectively, in CHF than in control subjects
convective O2 transport) (Table 2, Fig. 2). At maximal
ycle and KE exercise, DMO2 (diffusive O2 transport) was
2% and 22% lower in the CHF patients, respectively, than
n control subjects (Table 2, Fig. 2). The difference between
rterial and venous oxygen content (CaO2  CvO2), a
ariable that can be affected by both convective and diffusive
2 transport, was not different between patients and control
ubjects during both cycle and KE exercise (Fig. 2).
atecholamines. Measurements of arterial and venous
pinephrine, NE, and blood flow to facilitate the calcu-
ation of NE spillover from the muscle during maximal
ycle and KE exercise revealed a greater arterial NE
oncentration during KE exercise in the patients and
reater NE spillover during both exercise modalities in
he patients with CHF (Table 3).
NE Spillover From thentrol Subjects and CHF PatientsCa cu at d NE Spillover From the
ercise in Control Subjects and CHF Patients
KE
CHF Control Subjects CHF
65 0.1 0.64 0.1 0.89 0.3
43 0.1 0.38 0.1 0.39 0.1
.1 3.6 4.0 0.9 9.0 2.1*
.9 5.8 3.7 0.9 6.7 2.4
01 2.2* 1.82 0.43 3.31 0.65*
llover from the muscle during maximal cycle and knee-extensor (KE)
F) (n  12). Results are expressed as mean  SEM. *p  0.05 (CHFFigure 2 Oxygen Transport and Use
A comparison of oxygen transport and use parameters assessed at maximal
cycle (A) and knee-extensor (KE) (B) exercise in patients with chronic heart
failure (CHF) (n  12) and control subjects (n  8). Control data have been
normalized to 100% as a point of reference for the data collected in the
patients with CHF. CaO2-CvO2  arterial-venous oxygen content difference;
DMO2  diffusional oxygen conductance; leg VO2  1-leg oxygen uptake;
QO  1-leg oxygen delivery.Arterial and Venous Epinephrine, NE, and CalculatedMuscle During Maximal Cycle and KE Exercise in CoTable 3 Arterial and Venous Epinephrine, NE, andMuscle During Maximal Cycle and KE Ex
Cycle
Control Subjects
[e]a (nmol/l) 0.86 0.2 0.
[e]v (nmol/l) 0.76 0.2 0.
[NE]a (nmol/l) 8.6 2.0 13
[NE]v (nmol/l) 8.4 1.3 13
NE spillover (nmol/l/min/kg) 2.47 0.53 7.
Arterial and venous epinephrine, norepinephrine (NE), and calculated NE spi
exercise in control subjects (n  8) and patients with chronic heart failure (CH
vs. control subjects).hrine concentration; [NE]a  arterial norepinephrine concentration;
pinephrine concentration.
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Limitations to Maximal Exercise in CHF May 4, 2010:1945–54he effect of 100% O2 breathing. At peak cycle exercise,
yperoxic breathing in CHF increased CaO2 by 10%
p  0.05), whereas it had no effect on leg blood flow.
herefore, leg O2 delivery increased similarly by 8% (p 
.05), and leg VO2 also increased by 7% (p 0.05) (Fig. 3).
n control subjects, O2 breathing increased CaO2 by 10%
nd also had no effect on leg blood flow. Leg O2 delivery
hereby increased by 8% (p  0.05), but leg VO2 was
nchanged (Fig. 3). At peak KE exercise, hyperoxic breath-
ng increased CaO2 in patients with CHF by 7% and in
ontrol subjects by 8% (p  0.05) and, without reducing
lood flow, increased O2 delivery (p  0.05) but had no
ffect on leg VO2 in either group (Fig. 3).
tructural and functional/structural data. The muscle
haracteristics for both patients with CHF and control
ubjects, determined from needle biopsy samples, revealed
hat mitochondrial volume density in the CHF group was
5% lower (p  0.05), compared with control subjects;
nd although not significant, there was a tendency for the
atients with CHF to exhibit smaller muscle fibers, which
esulted in a trend toward increased capillary density
Table 4). Additionally, there were several significant cor-
elations between both structural and functional/structural
ariables when data from both patients and control subjects
ere included (Figs. 4 and 5).
Figure 3 Effect of Hyperoxic Breathing
The effect of hyperoxia (100% oxygen) on peak leg VO2 assessed at maximal
cycle (A) and KE exercise (B) in patients with CHF (n  12) and control sub-
jects (n  8). Control data have been normalized to 100% as a point of reference
for the data collected in the patients with CHF. Abbreviations as in Figure 2.iscussion
large cardiac reserve during exercise was made accessible,
y experimental design, to CHF patients and control
ubjects by adopting 1-leg KE exercise, contrasted with
onventional 2-leg cycling, thereby reducing the recruited
uscle mass (Fig. 1). With this approach the peak leg VO2,
Figure 4 Capillarity and Peak Oxygen Uptake
The relationship between capillary/fiber ratio and peak VO2 assessed at maxi-
mal cycle (A) and KE exercise (B) in patients with CHF (n  9) and control
subjects (n  6). The decision to combine the correlation for both patients and
control subjects was based upon the limited number of the data points and
observation that the addition of the patients improved the original relation-
ship displayed by the control subjects. Abbreviations as in Figure 2.
astus Lateralis Muscle CharacteristicsTable 4 Vastus Lateralis Muscle Characteristics
Control Subjects
(n  6)
CHF
(n  9)
Fiber cross-sectional area (m2) 3,853 606 3,092 237
% area of type I fibers 41 4 37 4
% area of type II fibers 59 4 63 4
Capillary density (capillaries/mm2) 415 46 442 21
Capillary/fiber ratio 1.52 0.10 1.36 0.12
Number of capillaries around a fiber 3.8 0.1 3.3 0.3
Mitochondrial volume density (%) 4.4 0.4 3.3 0.3*
Lipid droplets volume density (%) 0.30 0.06 0.36 0.07
umber of subjects for cross-sectional area: chronic heart failure (CHF): n  7; control subjects:
 5. *p  0.05 (CHF vs. control subjects).
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May 4, 2010:1945–54 Limitations to Maximal Exercise in CHFormalized for the active muscle mass, was significantly
reater during KE exercise (with cardiac reserve) than cycle
xercise (without cardiac reserve). Likewise, O2-enriched
reathing increased O2 availability during both cycle and
E exercise, but this only increased peak leg VO2 during
ycling in the patients with CHF. Together, these observa-
ions imply that, during whole body exercise such as cycling,
ardiac output and O2 delivery contribute significantly to
he exercise limitation experienced by patients with CHF.
However, this multi-faceted research also provides evi-
ence that, despite improvements in muscle peak leg VO2
fforded by increased O2 availability, the convective and
iffusive components of O2 transport from blood to skeletal
uscle in patients with CHF are still compromised during
E exercise when compared with well-matched control
ubjects. Correlative assessment of the current morphomet-
ic and functional data reveal that CHF does not alter
everal important relationships that are highly predictive of
keletal muscle function and health. In the following text,
e provide a more detailed interpretation and attempt to
econcile these apparently conflicting findings.
vidence of a skeletal muscle metabolic reserve. In the
urrent study the assessment of cardiac output during both
ycle and KE exercise illustrates that, by switching from a
arge to a small muscle mass exercise modality, a cardiac
eserve was consistently available to both patients with CHF
nd control subjects (Table 2). With this important proof of
oncept in place, the measurement of peak 1-leg VO2 and
he subsequent normalization to muscle mass involved in
he exercise (8), a clear muscle blood flow and metabolic
eserve was revealed in patients with CHF and control
ubjects that was accessible during KE exercise (Table 2).
Figure 5 Mitochondrial Volume and Capillarity
The relationship between mitochondrial volume and number of capillaries
around a muscle fiber in patients with chronic heart failure (CHF) (n  9) and
control subjects (n  6). The decision to combine the correlation for both
patients and control subjects was based upon the limited number of the data
points and observation that the addition of the patients improved the original
relationship displayed by the control subjects.his finding in patients with CHF was identical to that of (ontrol subjects. Presumably, this was a consequence of the
ocumented cardiac reserve associated with this exercise
odality. Many prior studies have suggested that CHF-
nduced skeletal muscle exhibits a shift in fiber type distri-
ution, reduced oxidative capacity, reduced mitochondrial-
ased enzymes, and decreased mitochondrial volume
ensity, all as a consequence of muscle atrophy or myopathy
r both (1–4). Therefore, in this population, it is a signif-
cant observation that there seems to still be a metabolic
eserve at maximal exercise, as revealed by freeing the
keletal muscle from the restraints imposed by the failing
eart.
In the present study, we found that patients with CHF
xhibited a skeletal muscle metabolic reserve, by signifi-
antly increasing peak VO2, while breathing 100% O2
uring maximal cycle exercise but not during KE exercise
Fig. 3). That is, when breathing hyperoxia—which resulted
n an elevated arterial O2 content—these patients were able
o achieve a 5% greater cycle work rate and a 7% increase in
eak VO2. This was in contrast to the healthy control
ubjects who failed to increase peak VO2 above that attained
n normoxia in both modalities. This suggests that during
ycle exercise the skeletal muscle of patients with CHF was
imited by O2 supply, and this was not the case during KE
xercise in which O2 delivery/unit of muscle mass was
lready significantly elevated in comparison with cycle
xercise. The control subject responses were consistent with
he published data in terms of healthy but sedentary human
uscle failing to improve when provided with greater O2
vailability (16,30), suggesting ambient O2 levels are either
erfectly matched or in excess of metabolic capacity in these
ealthy but sedentary subjects.
ontribution of convective and diffusive O2 transport in
imiting peak VO2. The current data afford the opportu-
ity to assess the contributions of both the convective (bulk
elivery of O2) and diffusive (movement of O2 from
emoglobin to mitochondria) elements in determining peak
O2 in CHF patients. A reasonable method by which to
nderstand these interactions is by the representation of
oth the diffusive component of O2 transport, which is
efined by Fick’s law of diffusion (VO2  DMO2  PvO2),
nd the convective component, which is defined by the Fick
rinciple (VO2  blood flow [CaO2 – CvO2]), in a model
hat links peak VO2 and effluent muscle O2 partial pressure
PvO2) to explain limitations to maximal exercise capacity
Fig. 6) (15). If we first consider the scenario of cycle
xercise, here it can be clearly seen that if the only difference
etween the control subjects and the CHF patients were the
educed convective component of O2 transport (reduced
ardiac output) (Table 2), then peak VO2 would have fallen
rom A to B as a result of this pathology (6). However, the
HF patients also revealed a significantly attenuated DMO2
diffusive component) (Fig. 2) in addition to the lower
onvective component of O2 transport, which actually
esulted in a greater fall in peak maximal VO2 from A to C
Fig. 6). It is important to recognize that, on the basis of the
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Limitations to Maximal Exercise in CHF May 4, 2010:1945–54urrent findings, the same schematic can be used to illustrate
he results of the KE exercise studies. This is because,
lthough cycle exercise was undoubtedly completely taxing
ardiac output capacity and KE exercise had a cardiac
eserve (Table 2), both the convective and diffusive compo-
ents of O2 transport of the patients with CHF were
iminished in both exercise models (Figs. 2 and 6).
The explanation for these apparently similar limitations
o maximal exercise in what seem to be very different
cenarios might well uncover the peripheral difference be-
ween control subjects and patients with CHF. Specifically,
ccording to their documented cardiac output capacity
uring cycle exercise, the patients with CHF could be
xpected to match the KE exercise blood flow of the control
ubjects (14); however, these patients did not (Table 2). It is
peculated that this might have been the result of the
ontinued relatively elevated NE spillover in the KE exercise
odel that was also apparent during cycle exercise (Table 3).
his increase in NE spillover is a plausible explanation for
he attenuated blood flow and thus lower convective
2 transport during KE exercise (Figs. 2 and 6). However,
ith the current approach, the potential role of heart failure
edications (only beta-blockers were discontinued) in this
ttenuated peripheral muscle blood flow response cannot be
Figure 6 Convective and Diffusive
Components of O2 Transport
A schematic illustration of the convective and diffusive components that inter-
act to determine peak oxygen uptake (VO2) in both CHF and control subjects
during both cycle (large muscle mass) and KE exercise (small muscle mass). In
both scenarios patients with CHF exhibit an attenuated diffusional conductance
(slope of the Fick law line). Additionally, it should be noted that the Fick princi-
ple lines are not straight, because they are directly reflective of the hemoglobin
dissociation curve. Therefore, a left-shifted hemoglobin dissociation curve
(greater hemoglobin oxygen affinity), resulting in a lower venous oxygen partial
pressure (PO2), will bisect the Fick law line earlier and reduce maximal VO2
and vice versa. This would be the equivalent of anchoring the existing CHF Fick
principle line at its origin on the x axis and altering its shape (a left-shifted O2
dissociation curve) to pass through point D (reduced peak VO2) or a right-
shifted O2 dissociation curve that would pass through point E (elevated peak
VO2). Explanations for point A, B, and C are given in the text. Abbreviations as
in Figure 2.uled out. rTo better understand the diffusive O2 transport differ-
nces between the patients and control subjects, it is worth
ighlighting the findings related to the arterial–venous O2
ifference that was similar between groups and the DMO2
hat was significantly attenuated in the patients with CHF.
his can be explained by the fact that the lower blood flow
xhibited by the patients with CHF allows for a longer
apillary transit time and therefore a greater time for O2
xtraction and the maintenance of arterial–venous O2 dif-
erence. However, DMO2—which is expressed per unit of
ime—takes this longer period for gas exchange into ac-
ount and reveals that, despite the adoption of a small
uscle mass exercise model, DMO2 remained significantly
ttenuated in the patients with CHF compared with control
ubjects (Figs. 2 and 6). This distinction between arterial–
enous O2 extraction—which is a consequence of both
onvective O2 delivery and diffusive O2 transport—and
MO2—which is solely a consequence of diffusive move-
ent—provides important mechanistic insight into the
imitations to O2 transport specific to patients with CHF.
ndeed, these data reveal that, during both cycle and KE
xercise, the patients with CHF exhibit an attenuated
bility to move O2 from blood to cell, and this contrib-
tes to the reduction in exercise capacity in both scenar-
os.
Finally, to gain a complete understanding of this model
nd the determinants of peak VO2, it is interesting to
ote that previously, with animal models, our group has
xperimentally supported the concept that manipulations
n O2 driving force from blood to cell (changing hemo-
lobin O2 affinity, see Fig. 6 legend) do indeed yield the
redicted changes in peak VO2 (9,31). Additionally and
pecifically germane to the topic of improving the diffu-
ional O2 transport to muscle in CHF, it was recently
ocumented that decreasing O2 affinity (right shifting the
2 dissociation curve) improved exercise capacity in mice
ith CHF (32), suggesting that this might indeed be one
echanism by which exercise capacity can be improved in
his pathology.
keletal muscle structure and functional relationships in
HF. A significant strength of the current study is the
otential to not only examine the skeletal muscle structure
ut also to combine these data with the functional assess-
ent of peak VO2 during both cycle and KE exercise
Fig. 4). Indeed, other such studies of skeletal muscle
tructure and function within and between species have
evealed design features that are uniform throughout mus-
les of widely varying metabolic demand. One of these
eatures is that the size of the capillary-to-fiber interface
ather than diffusion distance relates most closely to the
tructural capacity for O2 flux into muscle fibers (33). Here
gain, a degree of normality is apparent in the patients with
HF who demonstrate essentially the same relationship as
ontrol subjects for capillary-to-fiber ratio and peak VO2
uring both cycling and KE exercise (Fig. 4). Additionally,
ecent studies have revealed that the size of the capillary-
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May 4, 2010:1945–54 Limitations to Maximal Exercise in CHFo-fiber interface is matched to mitochondrial volume/fiber
ength in response to stimuli such as chronic hypoxia (34),
lectrical stimulation (35), and physical activity (36). These
bservations suggest that another regulated design feature in
keletal muscle is matching the structural capacity for O2
ux to fiber metabolic demand (36). Therefore, the current
ata, in which mitochondrial volume seems to be well-
elated to the number of capillaries around a muscle fiber,
eveal a positive and physiologically expected relationship
hat was similar for control subjects and CHF patients alike.
hus, although on average the patients had a significantly
educed mitochondrial volume and not a significantly re-
uced number of capillaries around a muscle fiber, the
elationship between these 2 variables was, as expected,
easonably strong (Fig. 5).
With the backdrop to this study being the goal to include
ontrol subjects who were well-matched with the CHF
atients (relatively inactive), the combined structure and
unctional relationships reported here suggest that the
atients exhibited relatively normal findings but still have
he tendency to exhibit the characteristics of inactivity
ompared with control subjects. Thus, the finding of an
ttenuated DMO2 in these patients cannot be simply attrib-
ted to structural abnormalities.
onclusions
his study has documented through a manipulation of
uscle mass recruitment during exercise that, even under
onditions where cardiac function is not limiting, both
keletal muscle blood flow—and therefore convective O2
ransport—and diffusion of O2 from blood to muscle are
ompromised. The explanation for these apparently sim-
lar limitations to maximal exercise in patients with CHF,
n what seem to be very different scenarios, supports a
ignificant peripheral difference between control subjects
nd patients. The peripheral factors that might contrib-
te to this limitation are numerous. Current data did not
pecifically implicate structural properties of the muscle
ut suggest that relatively elevated NE spillover might
lay a role by affecting local muscle blood flow. Such
onclusions must be tempered by recognition of the role
f numerous other vasoconstrictors and the possible
mpact of heart failure medications on regional blood
ow distribution.
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